Hepatitis C virus utilizes VLDLR as a novel entry pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 1, 2016, Pages 188-193

  Ujino, Saneyuki ^a   Nishitsuji, Hironori ^a   Hishiki, Takayuki ^b   Sugiyama, Kazuo ^c   Takaku, Hiroshi ^d   Shimotohno, Kunitada ^a  

^a National Center for Global Health and Medicine   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

CD81; Hepatitis C virus; Hypoxia; Virus entry; VLDLR

Indexed keywords

APOLIPOPROTEIN E; CD81 ANTIGEN; CHLORPROMAZINE; LENTIVIRUS VECTOR; OCLN PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; OCCLUDIN; OCLN PROTEIN, HUMAN; VERY LOW DENSITY LIPOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ECTOPIC EXPRESSION; ENDOCYTOSIS; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON CELL; VIRUS ENTRY; WESTERN BLOTTING; ANAEROBIC GROWTH; ANIMAL; CELL LINE; GENETICS; HEPACIVIRUS; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANAEROBIOSIS; ANIMALS; ANTIGENS, CD81; CELL LINE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; LIPOPROTEINS, VLDL; MICE; MICE, TRANSGENIC; OCCLUDIN; RECEPTORS, LDL; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

EID: 84953282769     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1506524113     Document Type: Article

References (31)

1. Pileri P, et al. (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938-941.
2. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801-805.
3. Ploss A, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882-886.
4. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017-5025.
5. Barth H, et al. (2006) Viral and cellular determinants of the hepatitis C virus envelopeheparan sulfate interaction. J Virol 80(21):10579-10590.
6. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96(22):12766-12771.
7. Sainz B, Jr, et al. (2012) Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18(2):281-285.
8. Martin DN, Uprichard SL (2013) Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci USA 110(26):10777-10782.
9. Lupberger J, et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17(5):589-595.
10. 436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. J Virol 80(16):7844-7853.
11. Owsianka AM, et al. (2006) Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol 80(17): 8695-8704.
12. Vassilaki N, et al. (2013) Low oxygen tension enhances hepatitis C virus replication. J Virol 87(5):2935-2948.
13. Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 15(6):1239-1253.
14. Shen GM, et al. (2012) Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia. Biochem J 441(2):675-683.
15. Ruiz J, et al. (2005) The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 46(8):1721-1731.
16. Reddy SS, Connor TE, Weeber EJ, Rebeck W (2011) Similarities and differences in structure, expression, and functions of VLDLR and ApoER2. Mol Neurodegener 6(30):1-10.
17. Wu JM, Skill NJ, Maluccio MA (2010) Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB (Oxford) 12(9):625-636.
18. Ploss A, Rice CM (2009) Towards a small animal model for hepatitis C. EMBO Rep 10(11):1220-1227.
19. André P, et al. (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76(14):6919-6928.
20. Nielsen SU, et al. (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80(5): 2418-2428.
21. Chang KS, Jiang J, Cai Z, Luo G (2007) Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81(24):13783-13793.
22. Bartosch B, et al. (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278(43):41624-41630.
23. Sakai J, et al. (1994) Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem 269(3):2173-2182.
24. Rettenberger PM, et al. (1999) Ligand binding properties of the very low density lipoprotein receptor. Ligand binding properties of the very low density lipoprotein receptor. J Biol Chem 274(13):8973-8980.
25. Dorner M, et al. (2013) Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501(7466):237-241.
26. Oka K, et al. (1994) Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-densitylipoprotein receptor. Eur J Biochem 224(3):975-982.
27. Tateno C, et al. (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165(3):901-912.
28. Jo H, et al. (2013) Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology 57(4): 1366-1377.
29. Ishii N, et al. (2006) Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol 80(9):4510-4520.
30. Hishiki T, et al. (2010) Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 84(22):12048-12057.
31. Sugiyama K, et al. (2009) Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro. J Virol 83(13):6922-6928.